FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048190741> ?p ?o ?g. }

• W3048190741 abstract "Targeting immune checkpoints, such as PD-1, represents a promising approach for cancer immunotherapy, achieving long-term disease remission rates in numerous types of cancer. T cell immunoglobulin and ITIM domain (TIGIT) is a checkpoint receptor associated with the antitumor roles of NK and T cells. Notably, the blockade of TIGIT has been revealed as a potential promising approach in cancer immunotherapy. However, the therapeutic potential of blocking TIGIT in myelodysplastic syndrome (MDS) remains unclear and further research is required to reveal their role.Fresh peripheral blood (PB) and bone marrow (BM) were obtained from patients with MDS and healthy donors (HDs) at the Tianjin Medical University General Hospital between January 21 2018 and March 22 2019. The present study investigated the expression levels of TIGIT on NK and T cells using flow cytometry (FCM) and PCR. In addition, other checkpoint receptors, such as CD226 and PD-1, were also investigated. To determine the mechanisms of antitumor immunity, the functions of NK and T cells expressing TIGIT were determined.TIGIT was found to be highly expressed on NK and T cells of the PB, where it was involved in disease progression and the immune escape of MDS. The high expression levels of TIGIT were associated with decreased NK and T cell function, and significantly lower secretions of activation factors, such as CD107a, IFN-γ and TNF-α. Notably, blocking TIGIT enhanced the antitumor effects of NK and T cells.The results of the present study suggested that targeting TIGIT alone or in combination with PD-1 may be a promising anticancer therapeutic strategy in MDS." @default.
• W3048190741 created "2020-08-13" @default.
• W3048190741 creator A5005244586 @default.
• W3048190741 creator A5042886775 @default.
• W3048190741 creator A5053225394 @default.
• W3048190741 creator A5053269101 @default.
• W3048190741 creator A5064204355 @default.
• W3048190741 creator A5076699095 @default.
• W3048190741 creator A5090783686 @default.
• W3048190741 date "2020-08-07" @default.
• W3048190741 modified "2023-10-17" @default.
• W3048190741 title "Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes" @default.
• W3048190741 cites W1572200743 @default.
• W3048190741 cites W1841418760 @default.
• W3048190741 cites W1958987550 @default.
• W3048190741 cites W1983973479 @default.
• W3048190741 cites W1985685212 @default.
• W3048190741 cites W1987165863 @default.
• W3048190741 cites W2006753987 @default.
• W3048190741 cites W2008611846 @default.
• W3048190741 cites W2027470770 @default.
• W3048190741 cites W2029399624 @default.
• W3048190741 cites W2091064887 @default.
• W3048190741 cites W2129430680 @default.
• W3048190741 cites W2239788766 @default.
• W3048190741 cites W2339658711 @default.
• W3048190741 cites W2342968295 @default.
• W3048190741 cites W2534828940 @default.
• W3048190741 cites W2564906907 @default.
• W3048190741 cites W2574468213 @default.
• W3048190741 cites W2583113562 @default.
• W3048190741 cites W2626126745 @default.
• W3048190741 cites W2790293865 @default.
• W3048190741 cites W2803225762 @default.
• W3048190741 cites W2808301581 @default.
• W3048190741 cites W2808601843 @default.
• W3048190741 cites W2811322579 @default.
• W3048190741 cites W2879746793 @default.
• W3048190741 cites W2892839743 @default.
• W3048190741 cites W2899058237 @default.
• W3048190741 cites W2907929175 @default.
• W3048190741 cites W2914486061 @default.
• W3048190741 cites W2918806228 @default.
• W3048190741 cites W2943316180 @default.
• W3048190741 cites W2946954163 @default.
• W3048190741 cites W2949403516 @default.
• W3048190741 cites W2966602502 @default.
• W3048190741 cites W2986344189 @default.
• W3048190741 cites W2995440672 @default.
• W3048190741 cites W2999805537 @default.
• W3048190741 cites W3000210355 @default.
• W3048190741 doi "https://doi.org/10.3389/fonc.2020.01595" @default.
• W3048190741 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7438899" @default.
• W3048190741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32903786" @default.
• W3048190741 hasPublicationYear "2020" @default.
• W3048190741 type Work @default.
• W3048190741 sameAs 3048190741 @default.
• W3048190741 citedByCount "33" @default.
• W3048190741 countsByYear W30481907412020 @default.
• W3048190741 countsByYear W30481907412021 @default.
• W3048190741 countsByYear W30481907412022 @default.
• W3048190741 countsByYear W30481907412023 @default.
• W3048190741 crossrefType "journal-article" @default.
• W3048190741 hasAuthorship W3048190741A5005244586 @default.
• W3048190741 hasAuthorship W3048190741A5042886775 @default.
• W3048190741 hasAuthorship W3048190741A5053225394 @default.
• W3048190741 hasAuthorship W3048190741A5053269101 @default.
• W3048190741 hasAuthorship W3048190741A5064204355 @default.
• W3048190741 hasAuthorship W3048190741A5076699095 @default.
• W3048190741 hasAuthorship W3048190741A5090783686 @default.
• W3048190741 hasBestOaLocation W30481907411 @default.
• W3048190741 hasConcept C159654299 @default.
• W3048190741 hasConcept C203014093 @default.
• W3048190741 hasConcept C2776090121 @default.
• W3048190741 hasConcept C2777701055 @default.
• W3048190741 hasConcept C2779118045 @default.
• W3048190741 hasConcept C2780674031 @default.
• W3048190741 hasConcept C2780851360 @default.
• W3048190741 hasConcept C45121317 @default.
• W3048190741 hasConcept C502942594 @default.
• W3048190741 hasConcept C553184892 @default.
• W3048190741 hasConcept C71924100 @default.
• W3048190741 hasConcept C86803240 @default.
• W3048190741 hasConcept C8891405 @default.
• W3048190741 hasConceptScore W3048190741C159654299 @default.
• W3048190741 hasConceptScore W3048190741C203014093 @default.
• W3048190741 hasConceptScore W3048190741C2776090121 @default.
• W3048190741 hasConceptScore W3048190741C2777701055 @default.
• W3048190741 hasConceptScore W3048190741C2779118045 @default.
• W3048190741 hasConceptScore W3048190741C2780674031 @default.
• W3048190741 hasConceptScore W3048190741C2780851360 @default.
• W3048190741 hasConceptScore W3048190741C45121317 @default.
• W3048190741 hasConceptScore W3048190741C502942594 @default.
• W3048190741 hasConceptScore W3048190741C553184892 @default.
• W3048190741 hasConceptScore W3048190741C71924100 @default.
• W3048190741 hasConceptScore W3048190741C86803240 @default.
• W3048190741 hasConceptScore W3048190741C8891405 @default.
• W3048190741 hasFunder F4320315254 @default.
• W3048190741 hasFunder F4320316085 @default.
• W3048190741 hasFunder F4320323993 @default.

• next